[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.75.176. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 17, 1952

INEFFECTIVENESS OF "KREBIOZEN" THERAPY ON TRANSPLANTED MOUSE LEUKEMIA AND LYMPHOSARCOMA

Author Affiliations

Southwest Foundation for Research and Education, 8500 Culebra Rd. San Antonio 6, Texas.

JAMA. 1952;149(3):298. doi:10.1001/jama.1952.02930200084024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  "Krebiozen," a substance obtained from the serum of treated horses, has been reported as possessing possible therapeutic value for human malignant tumors (Ivy, A. C., and others: Krebiozen: An Agent for the Treatment of Malignant Tumors, Chicago, Champlin-Shealy Co., 1951, pp. 1-106). The tests also indicated that it had no effect on a spontaneously occurring carcinoma in C3H mice nor on several transplanted tumors, including the C3HBA mammary carcinoma in C3H mice and the Jensen and Walker tumors in rats. No experimental details were given in the original publication, and, although a number of communications have since appeared (A Status Report on "Krebiozen," report of the Council on Pharmacy and Chemistry, J. A. M. A.147:864-873 [Oct. 27] 1951. Ivy, A. C.: Krebiozen, Science114:286, 1951. Rhoads, C. P.: Krebiozen, ibid. 114:285-286, 1951) no detailed reports concerning the effect of "krebiozen" on mouse neoplasms

First Page Preview View Large
First page PDF preview
First page PDF preview
×